Friday, March 14, 2025

Creating liberating content

Oracle Corp’s (NYSE: ORCL)...

Oracle Corp (NYSE: ORCL) falls down to its knees, share dropped over 12.15%...

RTX Corp (NYSE: RTX)...

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03...

GameStop Corp. (NYSE:GME) Quarter...

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after...

Advanced Micro Devices (NASDAQ:AMD)...

Shares of Advanced Micro Devices (NASDAQ:AMD) drops 0.38% in afterhours in last trading...
HomeTagsMerck (NYSE: MRK)

Tag: Merck (NYSE: MRK)

Ginkgo Bioworks (NYSE: DNA) Joins...

Ginkgo Bioworks (NYSE: DNA) drops 1.21% to...

Ginkgo Bioworks (NYSE: DNA) Joins Hand with Merck (MRK) To Improve Active Pharmaceutical Ingredient Manufacturing

Ginkgo Bioworks (NYSE: DNA) drops 1.21% to trade at $2.86 in early trading session on Tuesday after The company announces a cooperation with Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, to create up to four enzymes for use as biocatalysts in Merck's API production activities. Ginkgo will use its extensive experience in cell engineering and enzyme design, as well as its capabilities in automated high throughput screening, manufacturing process development/optimization, bioinformatics, and analytics, to deliver optimal strains for the expression of...

Ginkgo Bioworks (NYSE:...

Ginkgo Bioworks (NYSE: DNA) drops 1.21% to trade at $2.86 in early trading session on Tuesday after The company announces a cooperation with Merck...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!